LUKE DAVIS: Open Payments
NPI 1427408574 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 56 payments from 19 companies in 2025. Trend: 2023 $1,532 · 2024 $1,166 · 2025 $1,338
Food & beverage: $1,338
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $369 |
| Merck Sharp & Dohme LLC | 11 | $154 |
| Boston Scientific Corporation | 7 | $145 |
| Novartis Pharmaceuticals Corporation | 6 | $123 |
| Amgen Inc. | 5 | $77 |
| PFIZER INC. | 4 | $70 |
| Alnylam Pharmaceuticals Inc. | 2 | $58 |
| Esperion Therapeutics, Inc. | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Baxter Healthcare | 1 | $41 |
Products named: Rapiblyk, VERQUVO, WATCHMAN FLX, LEQVIO, ELIQUIS, REPATHA, ONPATTRO, NEXLETOL.
Industry payments across LA — which companies pay providers there.
